At a glance
ClinicalIndex Comparison RecordN/ACompleted· 234 enrolled
Drug / intervention
E-Cig Zero Nicotine +1 moredevice
Likely dose
E-Cig 24mg Nicotinefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Changes in Biomarkers Associated With Use of Electronic Cigarettes Among African American Menthol and Nonmenthol Smokers
In Brief
A clinical study evaluating E-Cig Zero Nicotine and E-Cig 24mg Nicotine for Biomarkers. Completed, enrolled 234 participants across 1 site.
Detailed Summary
The objective of this clinical trial was to compare the effects of e-cigarettes with and without nicotine on patterns of combustible cigarette use and biomarkers of exposure to tobacco toxicants among African American smokers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBiomarkers
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartNov 2016
First PostedMar 2017
Primary CompletionMar 2019
TodayJul 2026
First PostedMar 20, 2017
Enrollment StartNov 15, 2016
Primary CompletionMar 8, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 9.3 years ago
Interventions
E-Cig Zero Nicotinedevice
E-Cig Zero Nicotine
E-Cig 24mg Nicotinedevice
E-Cig 24mg Nicotine